ACOG-Recommended Terconazole Dose at 16 Weeks Gestation
For vulvovaginal candidiasis at 16 weeks gestation, use terconazole 0.4% cream 5 grams intravaginally daily for 7 days, as this is the standard topical azole regimen recommended for pregnant women. 1
Dosing Specifics
The FDA-approved dosing for terconazole vaginal cream 0.4% is:
- 5 grams (one full applicator) intravaginally once daily at bedtime for 7 consecutive days 1
Alternative terconazole formulations include:
- Terconazole 0.8% cream: 5 g daily for 3 days
- Terconazole 80 mg suppository: one suppository daily for 3 days 2
Rationale for Use in Pregnancy
Topical azole antifungals are the preferred treatment for vulvovaginal candidiasis during pregnancy. The 2021 CDC STI Treatment Guidelines, which inform ACOG recommendations, list terconazole among the recommended intravaginal agents for VVC treatment 2. At 16 weeks gestation (second trimester), you are well within the safe window for topical azole therapy.
Key Clinical Considerations:
Avoid oral fluconazole during pregnancy - While fluconazole 150 mg single dose is standard for non-pregnant patients 2, oral azoles should not be used in pregnancy due to potential teratogenic concerns
Treatment duration matters in pregnancy - The 7-day regimen with 0.4% cream is preferred over shorter 3-day courses, as pregnant women may require longer treatment duration for adequate cure rates 3
Efficacy is not affected by menstruation 1, so timing within the menstrual cycle is not a concern
Important Caveats
Confirm diagnosis before treatment - Before prescribing another course if symptoms persist, reconfirm diagnosis with microscopy and/or culture to rule out other pathogens 1
Systemic absorption is minimal - Only approximately 5-16% of terconazole is absorbed systemically over 7 days, with most remaining in the vaginal area 1, making it safe for use during pregnancy
The therapeutic effect and safety profile of terconazole has been established in both pregnant and non-pregnant women with similar pharmacokinetics 1, 3